New pill targets Alzheimer's in High-Risk gene carriers
Disease control
Completed
This study tested an oral drug called ALZ-801 in 84 people with early Alzheimer's who carry the APOE4 gene variant, which raises risk. The goal was to see if the drug affects key Alzheimer's-related proteins in the blood and brain, and to check its safety. Participants took the d…
Phase: PHASE2 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC